Clinical Trial

Comparison of Efficacy and Safety of Vita 6 Versus Zinc Along With Applied Behavioural Therapy

Completed
View on ClinicalTrials.gov →
Summary
The study seeks to fill the gaps in available local data regarding the diagnosis and its management, as multiple treatments are in practice. Therefore, the study aimed at the comparison of efficacy and safety of Vita 6 versus zinc along with applied behavioral therapy in the management of autism spectrum disorder in children aged 3-14 years.
Protocol Amendment History 1 change
critical Trial completed 2026-04-16
Trial Details
NCT Number NCT07383363
Lead Sponsor Muhammad Aamir Latif
Conditions Autism Spectrum Disorder
Enrollment 64 participants
Start Date 2025-09-23
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-15